Genentech Starts Pulling Back Psoriasis Drug

Raptiva, which had 2008 sales of $108 million in the United States, has been linked to a brain infection.

Original post by By REUTERS

Posts Related to Genentech Starts Pulling Back Psoriasis Drug

F.D.A. Panel Supports Avastin to Treat Brain Tumor
Preliminary studies of a blockbuster drug from Roche’s Genentech unit are strong enough to speed its approval for brain cancer, federal cancer experts said. Original ...
Morning Rounds: Everyday Poisonings, Psoriasis Drug Deaths and Wider Use of Statins
Health news from around the Web. Original post by By NICHOLAS BAKALAR
Brain Power: Brain Researchers Open Door to Editing Memory
An influx of money and talent into neuroscience has led to an experimental drug that could block certain memories, among other breakthroughs. Original post by ...
Treat your Xanax addiction
Xanax's generic name is Aprazolam. One of the reasons why Xanax is so popular nowadays is because it happens to be one of the mostly ...
Morning Rounds: Bikini Wax Injuries, Slowing Drug Sales and Postponed Health Care
Health news from around the Web. Original post by By RONI CARYN RABIN

Share and Enjoy:

No related posts.